Newfound Genomics is conducting clinical genomics research that specializes in complex gene disease research and development through gene validation studies, novel gene discovery and genotyping. Using integrated clinical measurements and genetic information derived from DNA samples, databases are then analyzed using bioinformatics.

These studies are intended to build a better understanding of the relationship between genes involved in health and disease that may contribute to an earlier diagnosis of disease, a more accurate prediction of the prognosis of disease and the development of more effective drugs for the treatment of disease.